🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-1.35 (-4.60%)
Nov 20, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
188.31244.41243.41198.41352196.11
Depreciation & Amortization
181.45183.14182.96181.96176.28179.75
Loss (Gain) From Sale of Assets
-0.440.09-0.17-6.10.050.15
Loss (Gain) From Sale of Investments
18.5914.323.071.85-70.492.22
Provision & Write-off of Bad Debts
0.02-0.01-2.6778.832.141.97
Other Operating Activities
-9.2124.0727.532.434.5444.65
Change in Accounts Receivable
-26.1319.06-52.17-61.46-29.3712.95
Change in Inventory
-82.63-43.3975.4471.53-130.2180.13
Change in Accounts Payable
-12.751.1243.77-87.5330.3336.01
Change in Unearned Revenue
-17.36-2.48-4.07-14.5310.9510.17
Change in Other Net Operating Assets
16.4923.76-70.67-22.7822.97-7.47
Operating Cash Flow
256.34464.08466.43342.61369.19556.63
Operating Cash Flow Growth
-46.49%-0.50%36.14%-7.20%-33.67%268.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-250.49-277.82-524.6-297.51-93.84-156.05
Sale of Property, Plant & Equipment
0.61-16.016.530.240.05
Sale (Purchase) of Intangibles
-8.14-3.22-1.32-3.22-0.33-3.69
Investment in Securities
-7-135-33.751.78-129.2
Other Investing Activities
-0.98-0.892.51-1.55-17.7-2.59
Investing Cash Flow
-266-281.94-372.39-329.51-109.85-291.48

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,7702,2202,5202,8102,475
Long-Term Debt Issued
-28.78175.22---
Total Debt Issued
3,7303,7992,3952,5202,8102,475
Short-Term Debt Repaid
--3,760-2,350-2,310-2,920-2,375
Long-Term Debt Repaid
--21.32-13.94-13.55-13.8-52.9
Lease Payments
-2.2-0.75-0.84-1.05-1.3-0.9
Total Debt Repaid
-3,671-3,781-2,364-2,324-2,934-2,428
Net Debt Issued (Repaid)
58.9117.4631.28196.45-123.847.1
Common Dividends Paid
-161.58-161.58-201.98-232.27-181.78-161.58
Other Financing Activities
0.36.11-0.270.0630.27-
Financing Cash Flow
-102.37-138.02-170.97-35.77-275.31-114.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
---0-0.060.06-0.01
Net Cash Flow
-112.0344.13-76.93-22.73-15.92150.66

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
5.85186.25-58.1745.1275.35400.58
Free Cash Flow Growth
198.93%---83.62%-31.26%558.08%
Free Cash Flow Margin
0.28%8.61%-2.64%2.10%14.19%22.50%
Free Cash Flow Per Share
0.061.84-0.570.452.723.96
Levered Free Cash Flow
-31.7912.29-165.25150.61192.96332.75
Unlevered Free Cash Flow
-26.0717.66-161.79155.1195.98334.96
Free Cash Flow After Leases
3.65185.51-59.0144.05274.04399.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.98.465.67.064.813.5
Cash Income Tax Paid
51.434.2333.8883.0744.6516.14
Change in Working Capital
-122.38-1.93-7.7-114.77-95.34131.79